// App-Quantinova.ai

1268 : Evaluating Numeric Rating Scale Versions of the 3 and 4 Visual Analog Scale (3/4-VAS) Composite Measures in Patients with Active Psoriatic Arthritis from the SELECT-PsA Program

Researchers

Presenter

  • William Tillett

Principal Investigators

  • Laura Coates

  • Mitsumasa Kishimoto

  • Arathi Setty

  • Tianming Gao

  • Ralph Lippe

  • Philip Helliwell

Medical Centers

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

  • Keio University School of Medicine, Yokohama, Japan

  • Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences,, Oxford University Hospitals NHS Trust, Oxford, UK, Oxford, United Kingdom

  • AbbVie, Inc, Wiesbaden, Germany

Locations

  • United Kingdom

  • Japan

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

Biomarkers

  • C reactive protein

  • Plasminogen Activator, Urokinase

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • Placebo Control

  • Active Comparator

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved